Drug · DIN 02513331
LIPRELOG
10 ML VIAL
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 21, 2025.
- Drug Identification Number (DIN)
- 02513331
- Company (DIN owner)
- Eli Lilly Canada IncToronto, Ontario, Canada
- Schedule
- Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Insulin lispro A10AB04
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INSULIN LISPRO | 100 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 22, 2021: NOC 25516New Drug Submission (NDS) · Additional product name
Other DINs named LIPRELOG
- DIN 02513358 · Cancelled Pre Market
- DIN 02513366 · Cancelled Pre Market
- DIN 02513374 · Cancelled Pre Market